Annals of Surgery · 1990 · 89 citations · 24 references
MedicineOncologySurgeryGastrointestinal OncologyGeneral SurgerySurgical OncologyGastric CancerGastric DiseasesGastrointestinal Cancer SurgeryGastrointestinal PathologyGastrointestinal SurgeryHormone-secreting TumorsAntisecretory TherapyControl Group DesignEnlarged Lymph NodesGastrinoma SurgeryGastrointestinal Oncologic SurgeryGastrointestinal TumorsHistorical Control ComparisonsSurgical Cure Rates
The role of surgery in the treatment of gastrinoma is unclear. The purpose of this study was to determine prospectively the surgical cure rate using a controlled clinical trial. Eleven patients who fit the entry criteria underwent abdominal exploration and attempted tumor resection for cure. A historical control group was used for comparison. Cure was defined as: (1) normal serum gastrin level, (2) no response to intravenous secretin, (3) no symptoms when antisecretory medications are stopped, and (4) no tumor recurrence on follow-up examination. Tumors found in both groups tended to be small (1.5 cm vs. 2.2 cm), multiple (71% vs. 40%), and in lymph nodes (70% vs. 70%). All tumors identified were located anatomically within the gastrinoma triangle. Tumors were found in 10 of 11 patients (91%) in the study group, and significantly more patients had their tumors excised for cure as compared to controls (82% vs. 27%, p less than 0.05). The current prospective cure rate for gastrinoma is higher than previously appreciated and tumors within lymph nodes do not preclude curative resection.
24
Rosalyn S. Yalow, Solomon A. Berson · Gastroenterology · 1970 · 804 citations
Medicine, Endocrinology, Physiology +15
The Zollinger-Ellison Syndrome
Edwin H. Ellison, Stuart D. Wilson · Annals of Surgery · 1964 · 454 citations · Full text
Jon I. Isenberg, John H. Walsh, Morton I. Grossman · Gastroenterology · 1973 · 394 citations